Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
302
NCT01638195
A Safety Evaluation of Renal Denervation Using Focused Therapeutic Ultrasound on Patients With Refractory Hypertension
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 30, 2012
Completion: Sep 30, 2014
NCT01704170
Feasibility Study to Evaluate Renal Denervation Using Focused Ultrasound
Phase: N/A
Start: Nov 30, 2012
Completion: Jun 30, 2014
NCT01926951
Renal Denervation Using Externally Focused Therapeutic Ultrasound
Start: Sep 30, 2013
Completion: Jun 30, 2015
NCT02029885
Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension
Start: Aug 31, 2014
Completion: Mar 31, 2018
NCT02480517
Sham Controlled Study of Renal Denervation for Untreated Stage I and II Hypertension
Start: Sep 30, 2016
Completion: Dec 31, 2017
NCT06608719
Retrospective Study on the Safety and Therapeutic/Improvement Effects of Intravenous Administration of SHED-CM for ALS (SHED-CAH2023)
Start: Dec 25, 2023
Completion: Jul 1, 2024
NCT06889857
Safety and Efficacy of Intravenous Administration of SHED-CM for ALS
Phase: Early Phase 1
Start: Apr 5, 2024
Completion: Dec 31, 2026